Form D · Biotechnology

CardioMech AS

Trondheim, Q8 · CIK 0001768128

Offering snapshot reported Apr 21, 2025 · SEC filing

Reported sold
$17.6M
Offering amount: $17.6M
Investors reported
58
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Apr 17, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 21, 2025Initial$17,560,063No comparison58SEC filing
Dec 20, 2023Initial$12,738,262No comparison100SEC filing
Feb 21, 2023Initial$4,528,164No comparison38SEC filing
Apr 29, 2022Initial$6,165,441No comparison34SEC filing
Aug 7, 2020Initial$9,200,000No comparison4SEC filing
Aug 19, 2019Initial$5,000,000No comparison54SEC filing
Feb 19, 2019Initial$2,525,000No comparison39SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-544109

Source: Form D, filed Apr 21, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jacob Bergsland Director
Vic, Jr. Bertrand Director
Vic Joseph Bertrand Director
Vic Bertrand, Jr. Director
Florian Eckhardt Director
Frederik Justin Gabriel Groenewegen Director
Jan Habrekke Director
Nikolai Hiorth Executive
Richard Nehm Director, Executive
Mark Novotny Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
Udbyes Gate 3a
Trondheim, Q8, 7030